
Overview
Financials
Revenue history (in k)
Filing timeliness
2 of 6 financial statements were filed late (the longest delay 89 days for 2021).
- 202524/06/2026
- 202414/07/2025
- 202318/08/2024
- 202215/07/2023
- 202112/10/2022
- 202011/10/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Offer
- Pharmaceutical products
- Medical products
- Dietary supplements
- Urinary tract support products
- Fertility support products
- Probiotic products
Website technology
- Online shop
- WooCommerce
- Website
- WordPress
Trademarks
Pharmnew holds 2 active trademarks registered with the Polish Patent Office. 1 application is pending. 3 marks have expired or were not registered. The first mark was filed in 2014.
| Mark | Protected until | |
|---|---|---|
| UROBIOX | Aug 20, 2031 | |
| UROCAL | Jun 4, 2034 | |
| NAVITIN(word) | – | |
| UROSTONEX SUPLEMENT DIETY | – | |
| UROZAX | – |
Authorized Representatives
Manner of representation
Each member of the management board is authorised to make declarations and sign on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Wojciech Edward Pawelecage 60 | 95 | $1,283.09 | 95% |
Others | 5 | $67.53 | 5% |
Beneficial owners
| Person | Rights |
|---|---|
Subsidiaries
| Name | Share value | Stake | ||
|---|---|---|---|---|
Ovipharmsp. z o.o. | 1,350.62 USD | 100% |
Bank accounts
Registered as a VAT taxpayer on 2014-01-01.
66 1050 1025 1000 0090 8482 6065
48 2490 0005 0000 4530 1006 6751
88 1090 1753 0000 0001 2287 6848
Debt
0 closed proceedings recorded in KRZ history.
Public aid
28 public aid cases recorded, with a total value of $34,379.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Feb 27, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $4,571$4,571 | Prezes Banku Gospodarstwa Krajowego | |
| Feb 27, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $804$804 | Prezes Banku Gospodarstwa Krajowego | |
| Feb 6, 2024 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $60$60 | Prezes Zakładu Ubezpieczeń Społecznych |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Kleemed Pharmaceuticals Polandsp. z o.o. | $847,166.12 | kleemed.com.pl | ||
| Novisc Pharmasp. z o.o. | $806,018.56 | novisc.com | ||
| Capeypharmasp. z o.o. | $723,168.08 | capeypharma.com | ||
| Biotic Biomesp. z o.o. | $689,147.75 | bioticbiome.pl | ||
| Biogentech Polskasp. z o.o. | $685,703.63 | biogentech.pl | ||
| Goodwill Pharma Polskasp. z o.o. | $664,724.30 | goodwillpharma.com | ||
| Pro Pedissp. z o.o. | $635,740.48 | propedis.pl | ||
| Dental Solutionssp. z o.o. | $611,683.37 | dentalsolutions.pl | ||
| Gursk Medicasp. z o.o. | $533,430.01 | gurskmedica.pl | ||
| Asmedi Internationalsp. z o.o. | $408,113.21 | asmediinternational.com |
Change history
| Date | Event | |
|---|---|---|
| 2025-07-15 | Address change (Ul. Wał Miedzeszyński 608, 03-994, Warszawa → Ul. Żegańska 21/23, 04-713, Warszawa) | |
| 2021-01-08 | Address change (Al. J. Waszyngtona 146, 04-076, Warszawa → Ul. Wał Miedzeszyński 608, 03-994, Warszawa) | |
| 2014-02-10 | Entered in the register |
FAQ
Last updated: 2026-06-25